Navigation Links
Medical researchers make important research link between active ingredient in saffron and MS
Date:11/4/2011

Medical researchers at the University of Alberta have discovered that an active ingredient in the Persian spice saffron may be a potential treatment for diseases involving neuroinflammation, such as multiple sclerosis.

Chris Power and a team of researchers in the Faculty of Medicine & Dentistry recently published their findings in the peer-reviewed publication, The Journal of Immunology.

"We found there is a compound in saffron, known as crocin, that exerts a protective effect in brain cell cultures and other models of MS. It prevented damage to cells that make myelin in the brain," Power said. "Myelin is insulation around nerves. MS is characterized by inflamed brain cells that have lost this protective insulation, which ultimately leads to neurodegeneration."

Power noted they are not close to a clinical trial stage yet, but the finding is still exciting.

It has been known in the research community for years that crocin protected neurons in certain situations, but Power and his team wanted to delve further into this area.

His team discovered that inflammation and a specific type of cell stress are closely linked and lead to neurodegeneration and inflammation which cause cells to lose their protective coating a process known as demyelination. In experiments conducted by Power and his colleagues, the use of crocin suppressed both inflammation and this specific type of cell stress, resulting in decreased neurological impairment in lab models and cell cultures with MS.

"There are still many questions to be answered about how crocin exerts these neuroprotective effects, but this research highlights a potential treatment role for crocin in diseases involving chronic neuroinflammation something that had not been recognized until now," says Power.

He explained the research demonstrates a new mechanism in MS, provides new potential drug targets in the future, and helps explain why physicians s
'/>"/>

Contact: Raquel Maurier
raquel.maurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Page: 1 2

Related biology news :

1. Athens Regional Medical Center Upgrades to Omnicell G4 Platform for Supply and Medication Management
2. Manufacturing microscale medical devices for faster tissue engineering
3. Lung regeneration closer to reality with new discovery by Weill Cornell Medical College researchers
4. 21 Fellows inducted into American College of Medical Informatics
5. Researchers at NYU Langone Medical Center review the microbiome and its possible role in cancers
6. BioCrossroads Invests in Medical Device Company Developing Revolutionary Absorbable Stent
7. Cell biologist Chris A. Kaiser to lead NIHs National Institute of General Medical Sciences
8. Virginia Tech biomedical engineers announce child football helmet study
9. Genomic sequence and comparison of 2 macaques reveal new insights into biomedical research
10. Medical College of Wisconsin researchers show molecule inhibits metastasis
11. Organic medical imaging system to detect disease and track medication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... this week on Washington DC,s Fox ... segment "The Next Great Thing", host Laura Evans ... and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... March 17, 2015 MedNet Solutions ... in clinical study management systems, is pleased to ... at ARENA,s Outsourcing in Clinical Trials Southeast conference ... provides an excellent forum for MedNet to showcase ... affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... songs of the humpback whale are among the most complex ... whales have their own syntax that uses sound units to ... last for hours. , Until now, only humans have demonstrated ... The research, published online in the March 2006 issue of ...
... grass inflorescence architecture because seeds of cereal grasses (e.g. ... , Grass seeds are borne on axillary branches, whose ... seen in the grasses. Maize produces two types of ... (female flowers and site of seed or kernel development). ...
... the neurotransmitter serotonin in the brain may also affect ... yet understood, say scientists from Georgetown University Medical Center ... investigators found, for the first time, that serotonin is ... that the chemical is specifically used to activate an ...
Cached Biology News:Warbling whales speak a language all their own 2Warbling whales speak a language all their own 3The evolution of food plants: Genetic control of grass flower architecture 2Commonly used antidepressants may also affect human immune system 2Commonly used antidepressants may also affect human immune system 3
(Date:4/17/2015)... 17, 2015 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD; ... that develops and commercializes proprietary technologies and products ... it has received approval from the TSX Venture ... common share purchase warrants ("the Warrants") of the ... Company,s May 2013 private placement financing. ...
(Date:4/17/2015)... LC Sciences LLC, a leading developer ... it is seeking beta testers for the VariantPro™ ... targeted sequencing technology. The system offers cost-effective, minimal ... detection of rare variants. It utilizes novel and ... will collaborate with beta testers to generate test ...
(Date:4/16/2015)... April 16, 2015 Cambridge ... solutions driven by Semantic Web technology, and ... information and services for the academic and scientific, ... its joint solution ‘Smart Data Lake for Clinical ... for the 2015 Bio-IT ‘Best of Show’ Award. ...
(Date:4/16/2015)... -- Schulman Associates IRB, Inc., the industry-leading central IRB in ... on Laboratory Drive in the heart of ... will house review board and service staff, which will ... customer service to clients. CBRE | ... deal, while Capital Associates Management, LLC represented the landlord.   ...
Breaking Biology Technology:SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Schulman IRB to Open Office in Research Triangle Park, N.C. 2
... Flulike Side-Effects Drives Physician Prescribing of Copaxone over an Interferon-Beta ... ... Resources, WALTHAM, Mass., March 11 ... focusing on pharmaceutical and,healthcare issues, finds that Teva Pharmaceutical,s Copaxone has ...
... 11 Altogen Biosystems,( http://www.altogen.com ) announced ... Las Vegas, NV, Altogen Custom Services focus ... Interference (RNAi) services, generation of stably-expressing cell,lines, ... the company will draw upon their unique ...
... Launch of Key ... Bavituximab Phase II Cancer Program-, TUSTIN, Calif., March 11 ... biopharmaceutical,company developing monoclonal antibodies for the treatment of cancer and,hepatitis ... quarter of fiscal year (FY) 2008 ended January 31, 2008. ...
Cached Biology Technology:Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 3Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services 2Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 2Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 3Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 4Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 5Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 6Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 7Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 8Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 9Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 10